Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Industry News

Penumbra Announces First Patient Enrolled In Study Of Mechanical Power Aspiration For Thrombus Removal In Coronary Vessels

October 10, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Industry News

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

May 02, 2019

News Industry News

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

April 05, 2018

News Industry News

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

May 05, 2017

News Industry News

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

September 27, 2016

News Industry News

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

December 15, 2015

News Industry News

XENIOS® AG receives CE mark for its i-cor® Synchronized Cardiac Assist System

November 24, 2015

News Industry News

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

October 14, 2015

News Industry News

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

October 13, 2015

News Industry News

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

August 18, 2015

News Industry News

UH Case Medical Center first in Ohio to implant new ventricular assist device

June 04, 2015

News Industry News

Maquet Announces Peer-Reviewed Publication Showing Larger Capacity Intra-aortic Balloon Pumps to have Greater Hemodynamic Effect on Patients

May 26, 2015

News Industry News

Trial Finds Benefits to Using Radial Versus Femoral Access for Primary Angioplasty in Heart Attack Patients

October 26, 2012

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Industry News

Data Presented at ACC.12 Demonstrate that OrbusNeich’s Genous™ Stent is Feasible and Safe in STEMI Patients

March 27, 2012

Advertisement

Penumbra Announces First Patient Enrolled In Study Of Mechanical Power Aspiration For Thrombus Removal In Coronary Vessels

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

XENIOS® AG receives CE mark for its i-cor® Synchronized Cardiac Assist System

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

UH Case Medical Center first in Ohio to implant new ventricular assist device

Maquet Announces Peer-Reviewed Publication Showing Larger Capacity Intra-aortic Balloon Pumps to have Greater Hemodynamic Effect on Patients

Trial Finds Benefits to Using Radial Versus Femoral Access for Primary Angioplasty in Heart Attack Patients

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

Data Presented at ACC.12 Demonstrate that OrbusNeich’s Genous™ Stent is Feasible and Safe in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content